Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myeloblastic Leukemia With Maturation
>>
CD Protein Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Mylotarg
(gemtuzumab ozogamicin) / UCB, PDL, Pfizer
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Campath
(alemtuzumab) / Sanofi
